The  ||| S:0 E:4 ||| DT
role  ||| S:4 E:9 ||| NN
of  ||| S:9 E:12 ||| IN
percutaneous  ||| S:12 E:25 ||| FW
endoscopic  ||| S:25 E:36 ||| FW
gastrostomy ||| S:36 E:47 ||| FW
( ||| S:47 E:48 ||| -LRB-
PEG ||| S:48 E:51 ||| NNP
) ||| S:51 E:52 ||| -RRB-
in  ||| S:52 E:55 ||| IN
palliative  ||| S:55 E:66 ||| NNS
care  ||| S:66 E:71 ||| VBP
The  ||| S:71 E:75 ||| DT
role  ||| S:75 E:80 ||| NN
of  ||| S:80 E:83 ||| IN
percutaneous  ||| S:83 E:96 ||| FW
endoscopic  ||| S:96 E:107 ||| FW
gastrostomy ||| S:107 E:118 ||| FW
( ||| S:118 E:119 ||| -LRB-
PEG ||| S:119 E:122 ||| NNP
) ||| S:122 E:123 ||| -RRB-
in  ||| S:123 E:126 ||| IN
palliative  ||| S:126 E:137 ||| JJ
care  ||| S:137 E:142 ||| NN
has  ||| S:142 E:146 ||| VBZ
not  ||| S:146 E:150 ||| RB
been  ||| S:150 E:155 ||| VBN
well  ||| S:155 E:160 ||| RB
discussed ||| S:160 E:169 ||| VBN
.  ||| S:169 E:171 ||| .
With  ||| S:171 E:176 ||| IN
the  ||| S:176 E:180 ||| DT
evolution  ||| S:180 E:190 ||| NN
of  ||| S:190 E:193 ||| IN
endoscopic  ||| S:193 E:204 ||| JJ
techniques  ||| S:204 E:215 ||| NNS
and  ||| S:215 E:219 ||| CC
PEG  ||| S:219 E:223 ||| NNP
devices ||| S:223 E:230 ||| NNS
,  ||| S:230 E:232 ||| ,
we  ||| S:232 E:235 ||| PRP
can  ||| S:235 E:239 ||| MD
perform  ||| S:239 E:247 ||| VB
PEG  ||| S:247 E:251 ||| NNP
more  ||| S:251 E:256 ||| RBR
safely ||| S:256 E:262 ||| RB
,  ||| S:262 E:264 ||| ,
even  ||| S:264 E:269 ||| RB
in  ||| S:269 E:272 ||| IN
difficult  ||| S:272 E:282 ||| JJ
cases ||| S:282 E:287 ||| NNS
.  ||| S:287 E:289 ||| .
Actually ||| S:289 E:297 ||| RB
,  ||| S:297 E:299 ||| ,
PEG  ||| S:299 E:303 ||| NNP
is  ||| S:303 E:306 ||| VBZ
very  ||| S:306 E:311 ||| RB
useful  ||| S:311 E:318 ||| JJ
in  ||| S:318 E:321 ||| IN
home  ||| S:321 E:326 ||| NN
care  ||| S:326 E:331 ||| NN
of  ||| S:331 E:334 ||| IN
cancer  ||| S:334 E:341 ||| NN
patients ||| S:341 E:349 ||| NNS
.  ||| S:349 E:351 ||| .
We  ||| S:351 E:354 ||| PRP
should  ||| S:354 E:361 ||| MD
discuss  ||| S:361 E:369 ||| VB
the  ||| S:369 E:373 ||| DT
indications  ||| S:373 E:385 ||| NNS
of  ||| S:385 E:388 ||| IN
PEG  ||| S:388 E:392 ||| NNP
in  ||| S:392 E:395 ||| IN
the  ||| S:395 E:399 ||| DT
field  ||| S:399 E:405 ||| NN
of  ||| S:405 E:408 ||| IN
palliative  ||| S:408 E:419 ||| JJ
medicine ||| S:419 E:427 ||| NN
.  ||| S:427 E:429 ||| .
We  ||| S:429 E:432 ||| PRP
suggest  ||| S:432 E:440 ||| VBP
the  ||| S:440 E:444 ||| DT
following  ||| S:444 E:454 ||| JJ
indications  ||| S:454 E:466 ||| NNS
for  ||| S:466 E:470 ||| IN
PEG ||| S:470 E:473 ||| NNP
:  ||| S:473 E:475 ||| :
1.Difficulty  ||| S:475 E:488 ||| CD
in  ||| S:488 E:491 ||| IN
ingestion  ||| S:491 E:501 ||| NN
of  ||| S:501 E:504 ||| IN
sufficient  ||| S:504 E:515 ||| JJ
quantities  ||| S:515 E:526 ||| NNS
of  ||| S:526 E:529 ||| IN
food  ||| S:529 E:534 ||| NN
and  ||| S:534 E:538 ||| CC
water  ||| S:538 E:544 ||| NN
because  ||| S:544 E:552 ||| IN
of  ||| S:552 E:555 ||| IN
pain  ||| S:555 E:560 ||| NN
on  ||| S:560 E:563 ||| IN
swallowing ||| S:563 E:573 ||| NN
,  ||| S:573 E:575 ||| ,
or  ||| S:575 E:578 ||| CC
an  ||| S:578 E:581 ||| DT
obstruction  ||| S:581 E:593 ||| NN
caused  ||| S:593 E:600 ||| VBN
by  ||| S:600 E:603 ||| IN
cancer.  ||| S:603 E:611 ||| CD
2.Normal  ||| S:611 E:620 ||| CD
gastrointestinal  ||| S:620 E:637 ||| CD
function.  ||| S:637 E:647 ||| CD
3.Expected  ||| S:647 E:658 ||| CD
survival  ||| S:658 E:667 ||| NN
time  ||| S:667 E:672 ||| NN
of  ||| S:672 E:675 ||| IN
more  ||| S:675 E:680 ||| JJR
than  ||| S:680 E:685 ||| IN
four  ||| S:685 E:690 ||| CD
weeks  ||| S:690 E:696 ||| NNS
in  ||| S:696 E:699 ||| IN
addition  ||| S:699 E:708 ||| NN
to  ||| S:708 E:711 ||| TO
absence  ||| S:711 E:719 ||| NN
of  ||| S:719 E:722 ||| IN
cachexia.  ||| S:722 E:732 ||| NNP
4.Patient ||| S:732 E:741 ||| NNP
's  ||| S:741 E:744 ||| POS
consent  ||| S:744 E:752 ||| NN
for  ||| S:752 E:756 ||| IN
PEG ||| S:756 E:759 ||| NNP
.  ||| S:759 E:761 ||| .
